Category Specific RSS

Optiscan

Optiscan receives FDA feedback to pursue de novo pathway for oral imaging

Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation…

2 years ago

Optiscan Imaging eyes FDA approval through $800k intellectual property acquisition from MD

Would you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah,…

3 years ago

Optiscan to expands distribution throughout China for tumour detection microscope

With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in…

3 years ago